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Abstract
Background: Convection-enhanced delivery (CED) of adenoviruses offers the potential of widespread virus distribution in
the brain. In CED, the volume of distribution (Vd) should be related to the volume of infusion (Vi) and not to dose, but when
using adenoviruses contrasting results have been reported. As the characteristics of the infused tissue can affect convective
delivery, this study was performed to determine the effects of the gray and white matter on CED of adenoviruses and similar
sized super paramagnetic iron oxide nanoparticles (SPIO).
Methodology/Principal Findings: We convected AdGFP, an adenovirus vector expressing Green Fluorescent Protein, a virus
sized SPIO or trypan blue in the gray and white matter of the striatum and external capsule of Wistar rats and towards
orthotopic infiltrative brain tumors. The resulting Vds were compared to Vi and transgene expression to SPIO distribution.
Results show that in the striatum Vd is not determined by the Vi but by the infused virus dose, suggesting diffusion, active
transport or receptor saturation rather than convection. Distribution of virus and SPIO in the white matter is partly volume
dependent, which is probably caused by preferential fluid pathways from the external capsule to the surrounding gray
matter, as demonstrated by co-infusing trypan blue. Distant tumors were reached using the white matter tracts but tumor
penetration was limited.
Conclusions/Significance: CED of adenoviruses in the rat brain and towards infiltrative tumors is feasible when regional
anatomical differences are taken into account while SPIO infusion could be considered to validate proper catheter
positioning and predict adenoviral distribution.
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Introduction
Convection-enhanced delivery (CED) is a novel way to cir-
cumvent the Blood-Brain Barrier (BBB) in the treatment of
diseases of the brain including gliomas and neurodegenerative
diseases [1–4]. Direct infusion of therapeutic agents into the
interstitial space has the potential to achieve a widespread local
distribution of the agent while minimising systemic degradation
and toxicity. Ideally, the distribution volume (Vd) following CED
is dependent on the infusion volume (Vi). Recent clinical trials
have shown the safety of CED in the treatment of Glioblastoma
Multiforme (GBM) [5–7]. In addition, these trials have illustrated
some of the technical challenges of CED and the need to monitor
the process of convection to prevent toxicity on one hand and
frank ineffectiveness due to limited convection on the other [8].
Adenoviral vectors or conditionally replicating adenoviruses
(CRAds) have been used preclinically and clinically in a variety
of intracranial diseases [9,10]. After intravascular, intrathecal or
intracerebral delivery, adenovirus distribution and therapeutic
effects are limited due to the presence of the BBB, limited diffusion
of injected viral particles or elimination by the activated immune
system [11–13]. As CED relies on bulk flow instead of diffusion, it
represents a promising method to deliver adenoviruses to the
brain. Thus far, controversy exists whether adenoviruses are
suitable agents for CED [14,15]. The size of the adenoviral
particle (70–90 nm) is considered to be an important determinant
of its distribution, although other factors have been suggested as
well [14,16].
Ideally, CED of adenovirus should be monitored by either
directly visualizing the viral particle, or by infusion of a surrogate
marker with similar CED-characteristics. To determine whether
regional anatomical differences influence adenoviral distribution
we convected an adenoviral vector expressing Green Fluorescent
Protein (GFP) into the gray and white matter of the rat brain.
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Additionally, we infused Superparamagnetic Iron Oxide Nano-
particles (SPIOs) as a surrogate tracer to predict the volume of
adenovirus distribution after CED, while proper infusate delivery
was confirmed by co-infusion of trypan blue. Finally, infiltrative
tumors were targeted using white matter tracts as the delivery
route for adenoviruses and SPIO.
Results
Albumin does not affect in vitro adenovirus infection
efficiency
Because most agents used for CED are stored and delivered in
solutions containing albumin we first investigated if the albumin
concentration would influence infection efficiency. To this end, we
subjected U-251MG glioma cells for 30 minutes to AdGFP in
medium containing various concentrations of human albumin. The
percentage of infected cells ranged from 5.660.6% (no HSA) to
3.960.4% (0.4% HSA). Although higher concentrations (0.4% and
4%) of HSA slightly decreased infection efficiency, the differences
were neither large nor significant (p.0.1 for all comparisons).
Infusion of AdGFP into rat striate – gray matter
AdGFP was infused in three different doses into the corpus
striatum of Wistar rats in 3 ml or 10 ml total volume at a rate of
0.33 ml/minute (figure 1A). In all cases, the area of GFP
expression was confined to the striate with minimal backflow
occurring into the white matter of the external capsule.
At the two lower virus doses, the Vd achieved with the two
infusion volumes (3 ml and 10 ml) was almost the same reaching
approximately 10 ml at 8.46106 iu and approximately 25 ml at
8.46107 iu (figure 1B). Infusing the maximum dose that could be
delivered (2.86108 iu in 10 ml) resulted in a further increase of Vd
to 46.269.8 ml, almost filling the complete striate. These results
demonstrate that the distribution of AdGFP in the rat striate is
dependent on the dose, rather than the infusion volume.
In an attempt to increase the interstitial space, mannitol was co-
infused but this did not change the resulting Vd (9.360.2 ml versus
10.260.7 ml, p.0.3; figure 1B).
Infusion of AdGFP into corpus callosum and external
capsule - white matter
AdGFP was infused into the most prominent white matter tract of
the rat (figure 2). In contrast to the striate, the typical anatomical
orientation of the corpus callosum and the external capsule,
thinning rapidly lateral from the corpus callosum, complicates
objective volume measurements. Increasing the infusion volume
from 3 ml to 10 ml increased the Vd insignificantly from 7.164.8 ml
to 962.5 ml. More relevant however, the maximum distance
traveled by the viral particles as shown by GFP expression following
infusion in 10 ml was on average 1.4-fold greater than following
infusion in 3 ml, both in the coronal (1.460.2, p,0.05) and the
sagittal (1.460.1, p,0.05) plane. The maximum distance from the
point of infusion traveled by the virus injected in 10 ml was 6.1 mm
in the coronal plane and 2.4 mm in the sagittal plane. These results
indicate that in the white matter, the distribution of adenovirus is at
least partly dependent on infusion volume.
Prediction of Adenoviral Vd by superparamagnetic iron
oxide nanoparticle infusion
25 mg of SPIO and 8.46106 iu adenovirus were co-infused in
either 3 ml or 10 ml into the rat striate or external capsule.
Adenovirus Vds and distribution patterns were comparable to
those found when Ads were infused without SPIO and the Vds of
co-infused SPIO and virus were completely overlapping
(figure 3A). In the striate, there was no increase in distribution
with increasing infusion volume, while in the corpus callosum and
external capsule viral spreading, as measured by the distance
covered by GFP expression, increased with increasing Vi. SPIO
Vds in the striate were 9.460.7 ml and 10.861.1 ml following 3 ml
and 10 ml infusion, respectively, comparable to the Vd of GFP
(figure 3B). In the white matter a similar relation between covered
distance and infusion volume was found for SPIO and adenovirus
(including a factor 1.4 difference between 3 ml and 10 ml). From
these results it appears that 64 nm SPIO and adenovirus distribute
in a similar fashion through the rat brain.
Glial cell infection by adenovirus
Axonal transport of GFP, especially in the white matter, could
theoretically have biased the determination of the actual Vd. As
Figure 1. Volumes of distribution (Vd) of adenoviral transgene
expression in rat striate. GFP expression following 3 ml (left side) or
10 ml infusion (right side) of AdGFP as detected by fluorescence
imaging using IVIS lumina imaging system. Vd was calculated from
serial slides by determining GFP expression. (A) Distribution after
infusion of AdGFP in 3 ml (upper) or 10 ml (lower) at increasing dose as
determined by IVIS fluorescence. Representative sections from rat
hemispheres are shown. (B) Vd of AdGFP infused in either 3 ml or 10 ml
with increasing dose. 8.4*106 iu (black bars), 8.4*107 iu (white bars) and
2.8*108 iu (gray bars). Differences between 3 ml and 10 ml infusion
volume at similar doses were not significant. Mannitol did not increase
Vd. Average Vd 6 SD is shown, * p,0.01 compared to lower dose.
doi:10.1371/journal.pone.0024396.g001
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GFP is not the most sensitive marker for the determination of the
type of infected cells, 8.46106 iu of Ad.LacZ was infused together
with 25 mg SPIO in 10 ml PBS. b-galactosidase is expressed from
this vector in the nuclei of infected cells, allowing for a more
specific determination of the type of infected cells by nuclear
morphology. Infected cells were primarily oligodendrocytes,
astrocytes and other glial cell types (figure 4). No infected neurons
were observed and no b-galactosidase positive cells were seen in
the overlying cortex, confirming that the GFP expression seen was
not due to axonal transport, but probably caused by GFP
expression in the myelin sheath forming glial cells. Therefore
adenovirus appeared to infect similar glial cell types in both white
and gray matter. Co-infused SPIO co-localized with infected
nuclei in both locations.
Co-infusion of SPIO and trypan blue
Adenovirus and SPIO distribution in the white matter increased
with increasing volume, but not as much as would be predicted on
the basis of the volume of the interstitial space (which would yield a
Vd/Vi ratio of 5). We hypothesized that the effect of CED of viral
particles in rat white matter might be limited by infusion fluid
partly entering the gray matter, while larger particles distributed
only in the white matter. To investigate this, SPIO were co-infused
with trypan blue into the external capsule and rats were
immediately sacrificed after infusion. As before, SPIO distributed
only in the white matter of the corpus callosum and the external
capsule. In contrast, trypan blue could be detected in the white
matter and extending into the gray matter of both overlying
neocortex and corpus striatum (figure 5A). In these particular
experiments, total Vds of SPIO were 8.966 ml (Vi = 3 ml, Vd/Vi
ratio 3.0) and 16.964 ml (Vi = 10 ml, Vd/Vi ratio 1.7). The
corresponding trypan blue Vds were 18.465 ml (Vd/Vi ratio 6.1)
and 47.163 ml (Vd/Vi ratio 4.7), showing effective trypan blue
convection with a high Vd/Vi ratio close to the predicted value.
This was confirmed by measuring the total fluorescence signal and
average fluorescence per unit volume (figure 5B). While similar
amounts of trypan blue were delivered (measured by total
fluorescence), infusion in a larger volume yielded a lower
fluorescence per volume due to distribution over a larger volume.
Targeting infiltrative tumors in the white matter
C6 infiltrative brain tumors located in the external capsule were
targeted via white matter tracts using a mixture of SPIO and
trypan blue or SPIO, AdGFP and AdD24-CMV-GFP. The latter
mixture was chosen as in vitro results showed that the replicating
AdD24-CMV-GFP at 100 iu/cell provided almost a 1000-fold
higher transgene expression in C6 cells when compared to AdGFP
(89.765.3% vs. 0.160.6% transduction, respectively, p,0.0001),
while AdGFP showed higher levels of transgene expression in
normal brain (data not shown).
Although tumor and infusion locations were several millimeters
apart, directly after infusion SPIO was noted at locations where
tumor cells infiltrated the white matter tracts (figure 6A). Neither
iron particles nor trypan blue showed efficient penetration into
solid tumor. Iron particles were noted surrounding single tumor
Figure 2. Distribution of adenoviral transgene expression in rat
corpus callosum and external capsule. 3 ml or 10 ml of AdGFP
containing 8.4*106 iu was infused into the external capsule. 30 mm
sections of one representative rat are shown. Left side of images: 3 ml
infusion, right side: 10 ml infusion. Slides are arranged in rostrocaudal
(from upper left to lower right) direction. GFP expression is extended
when virus is infused in 10 ml compared to bolus, both in coronal and
sagittal planes.
doi:10.1371/journal.pone.0024396.g002
Figure 3. Co-infusion of SPIO and AdGFP in rat striate and
corpus callosum. (A) Parallel 30 mm coronal sections three days after
infusion. GFP and HE & iron stained sections showing GFP expression in
external capsule and striate (left column) and corresponding iron
distribution (right column). Original magnification 56. (B) Vd of SPIO
(black bars) and AdGFP (white bars) following 3 ml or 10 ml infusion into
rat striate combined with AdGFP. No significant differences were noted.
Average Vd 6 SD are shown.
doi:10.1371/journal.pone.0024396.g003
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cells, appearing to be extracellular at this stage. Three days after
infusion of SPIO and adenovirus, GFP expression was seen at the rim
of tumors, co-localizing with iron distribution within the solid tumor
(figure 6B). Iron particles now appeared to be intracellular although
no differentiation between uptake in tumor cells and reactive
astrocytes could be made. Tumors that were located only just outside
the white matter in the cortex were not transduced (data not shown).
Discussion
In the current study we used a small diameter fused silica
infusion cannula to convect an adenoviral vector into the rat brain
and towards brain tumors. We show that while the volume of
distribution is related to infused dose in the gray matter of the
corpus striatum, it appears to be related to infusion volume in the
white matter of the corpus callosum and external capsule. In
addition we show that the distribution of Ads is similar to that of
similar sized SPIO that can thus be used to predict the distribution
of adenoviruses in the brain. Finally, distant tumors can be
reached by CED of adenoviruses, but penetration of these tumors
is limited.
The results have some important implications for the delivery of
adenoviruses in the treatment of neurologic diseases for which they
have recently been used and especially for brain tumors where the
migrated cells in the surrounding brain parenchyma, mainly
consisting of white matter, are the target of treatment [9,12,17].
Because the albumin concentration of the infusion fluid had no
influence on infection efficiency, a 4% albumin concentration
was chosen as this concentration has been shown to increase the
distribution volume of adenoviruses [16], possibly because
albumin stabilizes the viral solution and prevents aggregation of
viral particles [18], which could affect their distribution.
Ideally, CED of adenoviruses in a clinical setting should rely on
the infused volume instead of the infused dose, as this would
permit control over the desired distribution volume. Most of the
recent studies using adenoviral vectors in the brain did not
investigate the effect of infusion volume on the distribution of
adenoviruses [16,19–21]. One previous study that did, reported a
correlation to infused dose rather than infused volume when an
adenoviral vector was infused into the rat striate [14], which is
Figure 4. Determination of infected cells by nuclear morphol-
ogy (top 2 rows, original magnification 56 and 206, HE
staining). b-Gal staining shows glial cells are infected following
infusion of AdCMVLacZ in the rat striate (A) or external capsule (B). No
infected neurons were detected. No infected cells were detected in the
overlying neocortex. SPIO distribution (iron staining) is similar to b-
Galactosidase staining both in gray and white matter (bottom row,
original magnification 206).
doi:10.1371/journal.pone.0024396.g004
Figure 5. Determination of fluorescence of trypan blue and
SPIO distribution following CED into the external capsule.
Trypan blue fluorescence was detected using the IVIS Lumina system
and by fluorescent microscopy. Fluorescence was quantified using
ImageJ software. (A) Trypan blue is detected in the gray matter
surrounding the corpus callosum, while SPIO is confined to the corpus
callosum. Trypan blue is easily detected using fluorescent imaging. Both
IVIS imaging (left) and microscopy fluorescence imaging (lower right
panel, showing magnified view of the area marked white in left panel)
yield similar distribution patterns. Image shows coronal sections
through rat brain. Fluorescence signal showing in white. Right side
10 ml infusion, left side 3 ml infusion. Upper right panel shows
corresponding HE & iron staining in parallel section, showing SPIO
distribution confined to the corpus callosum and external capsule
(original magnification 56). (B) Trypan blue fluorescence used to
determine if CED was successful. Average fluorescence per ml
distribution volume is decreased on the 10 ml side due to the larger
Vd. Total fluorescence in both groups is similar indicating equal
delivered dose. Average fluorescence 6 SD is shown.
doi:10.1371/journal.pone.0024396.g005
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similar to the results obtained from the striatal gray matter
infusions in our study and other studies infusing large particles in
the striate [22,23]. These results suggest that sufficient room exists
in the interstitial space of the striate for viral particles to distribute
and that this distribution is not dependent upon convection,
but more likely on other factors such as receptor saturation or
diffusion. Because the width, or pore size, of gray matter
extracellular space is estimated to be 38–64 nm [24], it appears
likely that adenovirus distribution in the striate does not occur in
the parenchymal interstitium but along preferred routes such as
perivascular spaces which have a far greater diameter (500 nm)
[25]. This distribution pattern has previously been observed with
other large particles such as liposomes and adeno-associated
viruses and is thought to be dependent on cardiac pulsations that
propel the particles in the perivascular space [26–28]. The
observation in our study that the Vd/Vi ratio could increase well
beyond the expected value strongly suggests that such an active
transport also affects adenoviral distribution and could obscure
any effects from infusion driven bulk flow. In addition, the lack of
an increased Vd when mannitol is co-infused to extend the
interstitial space supports the concept of perivascular propagation
because the perivascular spaces have sufficient space to accom-
modate viral transport, even without the addition of mannitol.
In the white matter of the corpus callosum and external capsule,
the distribution of adenoviruses appears to be dependent on
infusion volume. This was however not reflected in a substantially
increased Vd. Most likely the adenoviral particle is confined to the
white matter whereas the infusion fluid is not, which we showed in
the experiments co-infusing trypan blue and SPIOs with the latter
exhibiting a similar distribution pattern as adenovirus. A possible
explanation for the differential distribution of adenoviruses in
white compared to gray matter could be related to differences in
ECS composition. Both electron microscopy and mathematical
analysis have shown that the white, but not the gray, matter ECS
is easily extended by edema or infusion fluid [29–31], possibly
enough to allow the transport of adenovirus by bulk flow. In
addition, glypican, a member of the heparan sulfate proteoglycans
that are known to act as co-receptors for adenovirus binding [32]
is expressed in gray but not white matter of the rat [33]. Increased
adenovirus binding to glypican in gray matter could also explain
the limited propagation of virus particles in gray matter.
Interestingly, in a study infusing Indian ink, it has been shown
that this large particle (250 nm) spreads diffusively through the
interstitial space of white matter but was confined to the
perivascular spaces in gray matter [34]. Assuming a similar
distribution pattern of adenoviruses would explain why the viral
particle is distributed by Vi dependent interstitial bulk flow in the
white matter and by perivascular transport in the striatal gray
matter.
Differential expression of transgene by neurons and glial cells
could partly explain the noted transgene distributions, as neuronal
cell bodies will be more abundant in gray matter. We observed no
differences in transduced cell types between white and gray
matter, showing only transgene expression in glial cells. Obviously,
these results do not rule out the infection of neurons by adenovirus
that has been observed by others [20,35] as transgene expression
may have been below detection limits. However, such a
differential expression would not likely explain the differences in
distribution volume when only the infusion volume is changed.
The scarcity of white matter in the rat brain compared to the
abundance in the human brain raises issues on the use of this
animal as a model for CED. From the current study we cannot
determine if the relation between Vi and Vd in white matter is
maintained when larger volumes are infused. Indeed, the larger
canine brain may be better suited for preclinical evaluation of this
technique [19,20,35]. In addition, the use of such a model would
provide the possibility to study the distribution of these particles in
other white matter tracts that may be clinically relevant.
Distribution patterns of SPIOs were comparable to those of
adenovirus. The SPIO used, ResovistH, has a hydrodynamic
diameter of 64 nm, which makes it comparable, though slightly
smaller, to adenovirus. Iron particles have been used to predict the
distribution of adeno associated viruses (AAV) by MRI [23]. From
the results of our experiments it appears that distribution of
adenovirus and SPIO is very similar and since MR imaging of
these agents has been shown to be feasible at a concentration of
1 mg/ml [22,23,36], which is slightly less than the concentration
used in this study, SPIO infusion could thus be considered to
confirm the proper positioning of CED catheters. This strategy
could be used to prevent adenoviral distribution to undesired
locations and to predict the distribution of adenoviruses following
CED.
When tumors located in the white matter were targeted by
infusing adenoviruses and SPIO from a distant location, we show
that while the particles reach and engulf infiltrating tumor cells,
infection of tumor cells or deposition of iron particles is confined to
the outer rim of the solid tumor parts. Even trypan blue does not
Figure 6. CED of trypan blue, SPIO and adenovirus targeting
infiltrative C6 tumors. When tumor infiltrated the white matter, iron
particles are seen engulfing tumor cells. Penetration into solid tumor is
limited either with SPIO (top two rows), trypan blue (A, bottom row) or
adenovirus infusion (B, bottom row). Bottom row trypan blue and GFP
images correspond to top row Perls stained images. (A) Iron and trypan
blue distribution directly after infusion. (B) Iron and GFP distribution
three days after infusion.
doi:10.1371/journal.pone.0024396.g006
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easily penetrate the solid tumor parts. In addition, when tumors
were located only slightly outside the main white matter tract, no
transduction of tumor cells was noticed. Factors explaining these
results may be the high interstitial pressure in solid tumors and the
increased tortuosity of brain tumor extracellular space limiting
diffusion of particles [37–39]. In the specific case of gene therapy,
these results imply that transduction of distant solid tumors using
non replicating vectors will prove to be cumbersome, but that this
technique might be used to reach solitary migrating tumor cells. In
addition, CED of replicating (oncolytic) adenoviruses might be
employed to provide a starting point for adenoviral oncolysis
following infection of the rim of solid tumor parts. Care should be
taken when using the C6 model in combination with viruses as the
allogeneity of this model might elicit strong immune responses,
even without the addition of viruses [40].
In CED, catheter placement is crucial. Our results suggest that
placement of catheters in the gray matter should be avoided when
convecting large particles such as adenoviruses. In addition we
show that CED of adenoviruses is incapable of delivering viral
particles in the gray matter using white matter tracts. These factors
should be considered when catheter planning is performed and
could possibly be integrated into models predicting convective
delivery [41].
In conclusion, the current study shows that CED of Adenovi-
ruses is feasible when gray and white matter differences are
considered and the distribution can be predicted by SPIO
infusion. The observed distribution pattern of adenovirus after
CED closely mimics the routes of migrating single tumor cells
[42,43], which could make CED of adenoviruses a suitable
delivery method to track these cells in the treatment of gliomas.
Materials and Methods
Ethics statement
All animal experiments were performed according to the
guidelines established by the European community and following
a protocol approved by the local ethical and scientific committees
on animal experiments at our institution.
Tumor cells and Adenoviral vectors
U-251MG malignant glioma cells and C6 rat glioma cells were
obtained from the ATCC (Manassas, VA) and maintained in
DMEM containing 10% Fetal Calf Serum (Gibco BRL Life
Technologies, Paisley, UK).
AdGFP and AdCMVLacZ are replication-deficient adenoviral
vectors carrying an expression cassette for enhanced green
fluorescent protein and the Escherichia coli b-galactosidase gene
respectively under control of the human CMV promoter in the
deleted E1 region of the adenoviral backbone and have been
described before [44,45]. Vectors were propagated on 293 cells
and purified by CsCl gradient according to standard techniques.
AdD24-CMV-GFP was constructed by inserting a GFP expression
cassette under control of the CMV promoter in the deleted E3
region of AdD24 [46], which carries a 24 bp deletion in the E1a
region, limiting replication to cells with a dysfunctional Rb
pathway [47]. AdD24-CMV-GFP was plaque purified and
propagated on A549 cells. Viral titers in infectious units (iu) were
determined by limiting dilution assay on 911 cells by hexon
protein staining 48 hours after infection.
Infection efficiency assay
U-251MG cells were plated in 96-well plates at 10,000 cells per
well. The next day, cells were washed in PBS and AdGFP was
added at 5 iu/cell for 30 minutes with human serum albumin
(HSA, Cealb, Sanquin, Amsterdam, the Netherlands) diluted in
serum-free DMEM. HSA concentrations were 0% (control),
0.04% (approximate CSF albumin concentration) 0.4% (approx-
imate concentration in cell culture medium containing 10% FCS)
and 4% (albumin concentration in normal human serum). After
this period, cells were washed three times in PBS, and fresh
complete culture medium was added. GFP expression was assessed
after 36 hours by FACS analysis. The infection efficiency of C6
cells was assessed by adding either AdGFP or AdD24-CMV-GFP
for one hour at 100 iu/cell and determining the percentage of cells
expressing GFP after 36 hours.
Infusion system
Pressure from a syringe pump (PHD 2000, Harvard Apparatus
Inc., Holliston, MA) was transmitted to a syringe by way of a non-
compliant and zero dead volume pressure transduction system
described by Lonser et al. [48] Infusate was loaded into a 10 ml
Hamilton gastight syringe (RN1701, Hamilton Comp., Reno, NV)
attached at one end to the pressure transduction system and on the
other side to a 168 mm outer diameter fused silica cannula. This
cannula was chosen as it showed minimal backflow in preliminary
experiments using an infusion rate of 0.33 ml/minute.
Animal experiments
Female Wistar rats weighing 250–300 grams (Harlan, Horst, the
Netherlands) were anesthetized by an intraperitoneal injection of
90 mg/kg ketamine and 10 mg/kg xylazine. The heads were
shaved and the rats were placed in a stereotactic frame (Stoelting
co., Wood Dale, IL). A midline incision was made to expose the
cranium where two 0.8 mm burr holes were made on either side
0.5 mm anterior and 3.5 mm lateral from the bregma. The tip of
the infusion cannula was lowered into the corpus callosum/
external capsule (3.5 mm) or caudate putamen (6 mm) of the rat.
3 ml or 10 ml of 4% HSA in PBS containing the indicated amounts
of AdGFP, AdCMVLacZ, 25 mg ResovistH (SPIO, ferucarbotran,
64 nm hydrodynamic diameter, Schering, Berlin, Germany), 1 ml
0.4% trypan blue (molecular weight 960, Sigma, St. Louis, MO),
or a combination of these were infused at a rate of 0.33 ml/minute.
To increase the extracellular space fraction, one group of rats
received AdGFP in 10 ml of a solution containing 4.2% mannitol.
Five minutes after the end of infusion the cannula was removed at
a rate of 0.5 mm/minute. Three to four rats per group were used.
In the tumor experiments 500,000 C6 glioma cells were injected
in a volume of 3 ml PBS 5.5 mm lateral and 0.5 mm anterior to
the bregma at a depth of 6 mm in the external capsule. Tumors
were allowed to grow for 4 days. After this period, a mixture of
SPIO and trypan blue or SPIO, AdGFP and AdD24-CMV-GFP
(10 ml at 0.33 ml/minute) was infused in the external capsule
(bregma +0.5 mm, lateral 3.5 mm, 3.5 mm deep).
Rats that were injected with adenovirus were sacrificed after 3
days, whereas rats that were injected with trypan blue were
sacrificed directly at the end of infusion. Sacrificing the rats was
performed by i.p. pentobarbital overdose (.120 mg/kg). Brains
were removed and snap frozen in liquid nitrogen for histochem-
istry and determination of GFP and b-galactosidase expression,
iron and trypan blue distribution.
Determination of volumes of distribution and
histochemistry
Rat brains were cut into 8 mm or 30 mm sections and slides were
assessed for GFP expression (green filter, 445–490 nm EX/515–
575 nm EM) or trypan blue fluorescence (far-red filter, 615–
665 nm EX/695–770 nm EM) by imaging using the IVIS Lumina
CED of Adenovirus into Rat Brain
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imaging system (Xenogen, Cranbury, NJ). The threshold level of
GFP expression was determined to be 10% of peak GFP
expression. The area of trypan blue staining was determined by
the observed area of fluorescence in ImageJ with 10% of peak
fluorescence set as threshold. b-Gal staining was performed
according to the manufacturer’s instructions (b-Gal Staining Set;
Boehringer Mannheim, Almere, The Netherlands).
Iron particles were detected by imaging of Perls stained sections.
Perls iron stain was done by incubating in equal parts of 2% HCl
and 2% potassium ferrocyanide yielding a blue reaction product.
Slides were counterstained using hematoxylin and eosin.
Volumes of distribution were determined by multiplying the
calculated areas of distribution in serial slides with the interslide
distances (300 mm).
Statistical analysis
Differences in infection efficiency and volumes of distribution
were compared by two-sided t-test. In all experiments, p,0.05 was
considered statistically significant.
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